Zobrazeno 1 - 10
of 1 286
pro vyhledávání: '"BLAY, JY"'
Autor:
Blay, JY, Tlemsani, C., Toulmonde, M., Italiano, A., Rios, M., Bompas, E., Valentin, T., Duffaud, F., Le Nail, LR, Watson, S., Firmin, N., Dubray-Longeras, P., Ropars, M., Perrin, C., Hervieu, A., Lebbe, C., Saada-Bouzid, E., Soibinet, P., Fiorenza, F., Bertucci, F., Boudou, P., Vaz, G., Bonvalot, S., Honoré, C., Marec-Berard, P., Minard, V., Cleirec, M., Biau, D., Meeus, P., Babinet, A., Dumaine, V., Carriere, S., Fau, M., Decanter, G., Gouin, F., Ngo, C., Le Loarer, F., Karanian, M., Meurgey, A., Dufresne, A., Brahmi, M., Chemin-Airiau, C., Ducimetiere, F., Penel, N., Le Cesne, A.
Publikováno v:
In European Journal of Cancer January 2024 196
Autor:
Blay, JY, Piperno-Neumann, S., Watson, S., Dufresne, A., Valentin, T., Duffaud, F., Toulmonde, M., Italiano, A., Bertucci, F., Tlemsani, C., Firmin, N., Bompas, E., Perrin, C., Ropars, M., Saada-Bouzid, E., Dubray-Longeras, P., Hervieu, A., Lebbe, C., Gantzer, J., Chaigneau, L., Fiorenza, F., Rios, M., Isambert, N., Soibinet, P., Boudou-Roquette, P., Verret, B., Ferron, G., Ryckewaert, T., Lebellec, L., Brahmi, M., Gouin, F., Meeus, P., Vaz, G., Le Loarer, F., Karanian, M., De Pinieux, G., Ducimetiere, F., Chemin, C., Morelle, M., Le Cesne, A., Penel, N.
Publikováno v:
In European Journal of Cancer October 2023 192
Autor:
Blay, JY, Palmerini, E., Bollard, J., Aguiar, S., Angel, M., Araya, B., Badilla, R., Bernabeu, D., Campos, F., CHS, Caro-Sánchez, Carvajal Montoya, A., Casavilca-Zambrano, S., Castro-Oliden, V, Chacón, M., Clara-Altamirano, MA, Collini, P., Correa Genoroso, R., Costa, FD, Cuellar, M., dei Tos, AP, Dominguez Malagon, HR, Donati, DM, Dufresne, A., Eriksson, M., Farias-Loza, M., Frezza, AM, Frisoni, T., Garcia-Ortega, DY, Gerderblom, H., Gouin, F., Gómez-Mateo, MC, Gronchi, A., Haro, J., Hindi, N., Huanca, L., Jimenez, N., Karanian, M., Kasper, B., Lopes, A., Lopes David, BB, Lopez-Pousa, A., Lutter, G., Maki, RG, Martinez-Said, H., Martinez-Tlahuel, JL, Mello, CA, Morales Pérez, JM, Moura, DS, Nakagawa, SA, Nascimento, AG, Ortiz-Cruz, EJ, Patel, S., Pfluger, Y., Provenzano, S., Righi, A., Rodriguez, A., Santos, TG, Scotlandi, K., MLG, Silva, Soulé, T., Stacchiotti, S., Valverde, CM, Waisberg, F., Zamora Estrada, E., Martin-Broto, J.
Publikováno v:
In Critical Reviews in Oncology / Hematology June 2022 174
Autor:
Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranchère-Vince D, Blay JY, Ray-Coquard I
Publikováno v:
Clinical Pharmacology: Advances and Applications, Vol 2012, Iss default, Pp 65-70 (2012)
Pierre Heudel,1 Philippe Cassier,1 Olfa Derbel,1 Armelle Dufresne,1 Pierre Meeus,2 Philippe Thiesse,3 Dominique Ranchère-Vince,4 Jean Yves Blay,1 Isabelle Ray-Coquard1,51Department of Medical Oncology, 2Department of Surgical Oncology, 3Department o
Externí odkaz:
https://doaj.org/article/b1967181c70045e88f03c8d5e700d598
Autor:
Perrier, L, Tredan, O, Morelle, M, Penel, N, Fournel, P, Greillier, L, Ghiringhelli, F, Tosi, D, Bertucci, F, Campone, M, Delord, JP, Pouessel, D, Garin, G, Chabaud, S, Gomez-Roca, C, Pannier, D, Brahmi, M, Fabbro, M, Garcia, ME, Ray-Coquard, I, Viala, M, Italiano, A, Cassier, P, Dufresne, A, Attignon, V, Treilleux, I, Viari, A, de la Motte Rouge, T, Durando, X, Perol, D, Blay, JY
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S175-S175
Autor:
Jones, RL, Blay, JY, Chi, P, Bauer, S, Gelderblom, H, Shen, L, He, YL, Heinrich, MC, Schöffski, P, Zalcberg, JR, Harrow, B, Sherman, ML, Ruiz-Soto, R, Becker, C, von Mehren, M
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S14-S15
Autor:
Blay, JY, Gelderblom, H, Rutkowski, P, Wagner, AJ, van de Sande, M, Stacchiotti, S, Le Cesne, A, Palmerini, E, Vallee, M, Harrow, B, Becker, C, Jarecha, R, Sharma, M, Tap, WD
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S15-S15
Publikováno v:
In Value in Health January 2022 25(1) Supplement:S227-S227
Publikováno v:
Health policy (Amsterdam, Netherlands). 123(12)
Background The use of targeted combination therapy (TCT) is becoming the standard of care in oncology as cancers are attacked through multiple inhibition mechanisms. TCTs pose a budget challenge to health systems and an economic return challenge for